Phase I trial of rebeccamycin analog (NSC #655649) in children with refractory solid tumors: a pediatric oncology group study.
about
Robust in vitro activity of RebF and RebH, a two-component reductase/halogenase, generating 7-chlorotryptophan during rebeccamycin biosynthesisNCI classification of thrombocytopenia in extremely preterm neonates and its association with mortality and morbidity.Phase I and Phase II Objective Response Rates are Correlated in Pediatric Cancer Trials: An Argument for Better Clinical Trial EfficiencyA comparison of safety and efficacy of cytotoxic versus molecularly targeted drugs in pediatric phase I solid tumor oncology trials.
P2860
Phase I trial of rebeccamycin analog (NSC #655649) in children with refractory solid tumors: a pediatric oncology group study.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Phase I trial of rebeccamycin ...... ediatric oncology group study.
@ast
Phase I trial of rebeccamycin ...... ediatric oncology group study.
@en
type
label
Phase I trial of rebeccamycin ...... ediatric oncology group study.
@ast
Phase I trial of rebeccamycin ...... ediatric oncology group study.
@en
prefLabel
Phase I trial of rebeccamycin ...... ediatric oncology group study.
@ast
Phase I trial of rebeccamycin ...... ediatric oncology group study.
@en
P2093
P1476
Phase I trial of rebeccamycin ...... ediatric oncology group study.
@en
P2093
Anne-Marie Langevin
John G Kuhn
Mark Bernstein
Pediatric Oncology Group Study
Steven D Weitman
Susan T Weintraub
Sylvain Baruchel
Teresa Vietti
Wayne Furman
P304
P356
10.1097/00043426-200307000-00006
P577
2003-07-01T00:00:00Z